Literature DB >> 2190769

Failure of nocturnal hypoglycemia to cause daytime hyperglycemia in patients with IDDM.

I B Hirsch1, L J Smith, C E Havlin, S D Shah, W E Clutter, P E Cryer.   

Abstract

To test the hypothesis that nocturnal hypoglycemia causes postprandial hyperglycemia the next day (the Somogyi phenomenon) in patients with insulin-dependent diabetes mellitus (IDDM), we studied 10 moderately well controlled patients, who were on their usual therapeutic regimens, from 2000 to 2000 on three occasions. On a control day, samples were obtained without intervention. On another day, nocturnal hypoglycemia was prevented (by intravenous infusion of glucose, if necessary, from 2200 to 0400 to keep plasma glucose levels at greater than 5.6 mM). On another day, nocturnal hypoglycemia was induced (by stepped intravenous insulin infusions between 2200 and 0200 to reduce plasma glucose levels to less than 2.8 mM). After nocturnal hypoglycemia (1.9 +/- 0.2 mM), fasting (0800), morning (0800-1100), afternoon (1200-1500), evening (1600-2000), and entire-day (0800-2000) plasma glucose concentrations were no higher than those after prevention of nocturnal hypoglycemia or sampling only. On the control day, fasting and daytime plasma glucose levels were directly related to the preceding 2200 (r = 0.723, P less than 0.02, and r = 0.762, P = 0.01, respectively) and nocturnal nadir (r = 0.714, P less than 0.02, and r = 0.728, P less than 0.02) plasma glucose concentrations. Daytime plasma glucose levels were unrelated to peak nocturnal plasma glucagon, epinephrine, norepinephrine, growth hormone, or cortisol concentrations. We conclude that nocturnal hypoglycemia does not appear to cause clinically important daytime hyperglycemia in patients representative of most patients with IDDM.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2190769     DOI: 10.2337/diacare.13.2.133

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  7 in total

1.  Comment to: Hoi-Hansen T, Pedersen-Bjergaard U, Thorsteinsson B (2005) The Somogyi phenomenon revisited using continuous glucose monitoring in daily life. Diabetologia 48:2437-2438.

Authors:  I Iseda; P E Lins; U Adamson; M Kollind
Journal:  Diabetologia       Date:  2006-04-04       Impact factor: 10.122

2.  Hypoglycemia impairs quality of blood glucose simulation in a clinical decision support system.

Authors:  Mette Dencker Johansen; Ole K Hejlesen; David A Cavan
Journal:  J Diabetes Sci Technol       Date:  2011-07-01

3.  Nocturnal electroencephalogram registrations in type 1 (insulin-dependent) diabetic patients with hypoglycaemia.

Authors:  I Bendtson; J Gade; A M Rosenfalck; C E Thomsen; G Wildschiødtz; C Binder
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

4.  Major Increases between Pre- and Post-breakfast Glucose Levels May Predict Nocturnal Hypoglycemia in Type 2 Diabetes.

Authors:  Soichi Takeishi; Akihiro Mori; Miyuka Kawai; Yohei Yoshida; Hiroki Hachiya; Takayuki Yumura; Shun Ito; Takashi Shibuya; Nobutoshi Fushimi; Noritsugu Ohashi; Hiromi Kawai
Journal:  Intern Med       Date:  2016-10-15       Impact factor: 1.271

5.  Investigating the Relationship between Morning Glycemic Variability and Patient Characteristics Using Continuous Glucose Monitoring Data in Patients with Type 2 Diabetes.

Authors:  Soichi Takeishi; Akihiro Mori; Miyuka Kawai; Yohei Yoshida; Hiroki Hachiya; Takayuki Yumura; Shun Ito; Takashi Shibuya; Nobutoshi Fushimi; Noritsugu Ohashi; Hiromi Kawai
Journal:  Intern Med       Date:  2017-06-15       Impact factor: 1.271

6.  Enlarged glycemic variability in sulfonylurea-treated well-controlled type 2 diabetics identified using continuous glucose monitoring.

Authors:  Fumi Uemura; Yosuke Okada; Keiichi Torimoto; Yoshiya Tanaka
Journal:  Sci Rep       Date:  2021-03-01       Impact factor: 4.379

7.  Confirmation of the Absence of Somogyi Effect in Patients with Type 2 Diabetes by Retrospective Continuous Glucose Monitoring Systems.

Authors:  Yuxin Huang; Xudan Lou; Weicong Huang; Jieyuzhen Qiu; Cuiping Jiang; Jiao Sun; Xiaoming Tao
Journal:  Int J Endocrinol       Date:  2022-10-04       Impact factor: 2.803

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.